Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Newborn screening and its relationship to the diagnosis and treatment of the disorder
Songya Pang(Illinois College), S. Kling(Oklahoma State Department of Health), Andrew Wallace(Heriot-Watt University), Annette Graters(Freie Universität Berlin), Laura Vilarinho(National Institute of Health Dr. Ricardo Jorge), Takako Kizaki(Tokyo Institute of Technology), Sumitaka Saisho, E. Dulín Íñiguez, Christine Papadea, Hiroshi Naruse, Masaru Fukushi, Agne Larsson, S. Piazzi(University of Bologna), Ulrika von Döbeln, Shohei Harada(Hokkaido University), Heather Dean(Health Sciences Centre), I Marzana(Hokkaido University), Christy LeBlond, J.M. de Winter(Health Sciences Centre), Osamu Arai(Hokkaido University), Antonio Balsamo(University of Bologna), Dianne Webster, Takio Yoyoura, Claes Guthenberg, Yusuhiro Kuroda, I Eguileor, Satoshi Kusuda(Kyorin University), Astrid Thilén, Lars Hagenfeldt, W. Hugh Craft(Oklahoma State Department of Health), Roberto Giugliani(Universidade Federal do Rio Grande do Sul), Frank Rumph, Kenji Fujieda(Asahikawa Medical College Hospital), Yoshiro Wada(Nagoya City University), Nobuo Matsuura(Sapporo University), C Gonzalez Gallego(Hokkaido University), Jean-Louis Dhondt(Hôpital Debrousse), Eurico Camargo Neto, Kazukiko Shimozawa, E Cacciari(University of Bologna), Y. Y. Kikuti, Yoshikiyo Mizushima, Nanaka Ichihara(Hokkaido University), J. P. Farriaux(Hôpital Debrousse), A. Campbell Clark(Illinois College), Masaru Matsumoto(Ishikawa Prefectural Nursing University), Seizo Suwa, Toni Torresani(University Children's Hospital Zurich)
Cited by 161
Related Papers
European Society for Paediatric Endocrinology Consensus Guidelines on Screening, Diagnosis, and Management of Congenital Hypothyroidism
|The Journal of Clinical Endocrinology & Metabolism|2014|569
Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
|New England Journal of Medicine|2016|555
Kabuki make‐up (Niikawa‐Kuroki) syndrome: A study of 62 patients
|American Journal of Medical Genetics|1988|457
Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study
|The Journal of Pediatrics|2006|364